Company Short-Term Debts: enzo.com (ENZ)

Public company logo of Enzo Biochem, Inc. (ENZ)

Enzo Biochem, Inc. (ENZ) relies on the automated production of diagnostic kits to reduce costs, while outsourcing logistics and IT system technical support to external contractors. The market value dynamics of the asset with the 0.00 indicator are clearly illustrated below. The company currently specializes exclusively in reagents, systematically refining its molecular formulas within a stable development cycle.

ENZ enzo.com Company Short-Term Debt (07/04/2022 - 04/26/2025)

Summary analytical data breakdowns for Enzo Biochem Inc. (ENZ)

- price and consensus price forecast:
Price Chart Enzo|ENZ - Broker Consensus Forecast
- market capitalization data:
Market Capitalization Enzo Biochem, Inc.|ENZ - Enterprise Value
- book capitalization data:
Net Assets per Single Share Enzo Biochem|ENZ - Company Book Value|Market Cap to Net Assets Ratio enzo.com|ENZ - Company Assets
- debt and liquidity data:
Debt to Equity Enzo Biochem, Inc.|ENZ - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Enzo|ENZ - Company Total Debt Obligations|Debt to Book Capitalization Ratio Enzo Biochem, Inc.|ENZ - Long-Term Debt Volume|Company Short-Term Debts Enzo Biochem
Fundamental company valuation:enzo.com ENZ
Product sample of Enzo Biochem Inc.

Enzo Biochem, Inc. (ENZ) revenues depend on the demand for diagnostic tests and government healthcare regulations, which directly impact cash flows. By analyzing historical short-term debt data, an investor can see the total obligations maturing within one year, allowing for an assessment of liquidity shortage risks and the company's overall cost of borrowed capital.

Competitors of Enzo Biochem, Inc. (ENZ)

Agilent (A) - Company Short-Term Debt|DGX - Company Short-Term Indebtedness|ILMN: Company Short-Term Debts|EXAS (Exact Sciences Inc.) - Company Short-Term Debts|Company Short-Term Debt Revvity, Inc.|Company Short-Term Debt bio-rad.com (BIO)|Anbio - Company Current Liabilities|Short-Term Debt SHC (Sotera Health Corp)|Company Short-Term Debt QDEL|Short-Term Debt Volume OPKO Health Corp. OPK|Company Short-Term Debts CDNA (CareDx, Inc.)|MRVI: Short-Term Debt Volume|Fulgent Genetics - Company Short-Term Debt|Standard BioTools Inc (LAB) - Short-Term Debt Volume|Company Short-Term Debts CTKB (Cytek Bio)|Short-Term Debt OSUR|Company Short-Term Debt Exagen Inc. XGN|Company Short-Term Indebtedness mdxhealth.com MDXH|Lucid Diagnostics (LUCD) - Company Current Liabilities|Prenetics Global Limited - Current Liabilities|IMDX (Insight Molecular) - Company Short-Term Debt|Trinity Biotech plc (TRIB) - Short-Term Debt|Company Current Liabilities ProPhase Labs, Inc. PRPH|ainos.com (AIMD) - Company Short-Term Loans and Borrowings|Company Short-Term Debts Co-Diagnostics|Company Short-Term Debt Heart Test Laboratories, Inc.|BMRA (Biomerica, Inc) - Company Short-Term Debts|Short-Term Debt Volume CDIO (cardiodiagnosticsinc.com)|VRAX: Company Short-Term Debt|Short-Term Debt bluejaydx.com BJDX|AWH: Company Short-Term Debts|AXDX - Company Current Liabilities|Company Short-Term Debts Centogene NV CNTG|Fresh2 Group (FRES) - Company Short-Term Loans and Borrowings|Company Short-Term Debts GENE (Genetic Technologies Ltd)|Short-Term Debt ME|Company Short-Term Debt PMD (Psychemedics Corporation)